vs
Side-by-side financial comparison of DiamondRock Hospitality Co (DRH) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
DiamondRock Hospitality Co is the larger business by last-quarter revenue ($258.2M vs $158.6M, roughly 1.6× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 5.6%, a 65.6% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 1.3%).
DiamondRock Hospitality Co is a US-based real estate investment trust owning and operating a portfolio of premium upscale hotels and resorts. Its properties are mainly located in major urban tourist and business hubs nationwide, catering to both leisure and corporate clientele seeking high-quality accommodation services.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
DRH vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $258.2M | $158.6M |
| Net Profit | $14.5M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 11.1% | 70.2% |
| Net Margin | 5.6% | 71.2% |
| Revenue YoY | 1.3% | 3661.1% |
| Net Profit YoY | 22.0% | 528.0% |
| EPS (diluted) | $0.07 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $258.2M | — | ||
| Q4 25 | $274.5M | — | ||
| Q3 25 | $285.4M | — | ||
| Q2 25 | $305.7M | — | ||
| Q1 25 | $254.9M | $158.6M | ||
| Q4 24 | $279.1M | $22.6M | ||
| Q3 24 | $285.1M | — | ||
| Q2 24 | $309.3M | — |
| Q1 26 | $14.5M | — | ||
| Q4 25 | $26.2M | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $40.8M | — | ||
| Q1 25 | $11.9M | $112.9M | ||
| Q4 24 | $-11.2M | $-10.5M | ||
| Q3 24 | $26.4M | — | ||
| Q2 24 | $24.5M | — |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 8.9% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 4.3% | 70.2% | ||
| Q4 24 | -3.7% | -60.4% | ||
| Q3 24 | 9.5% | — | ||
| Q2 24 | 8.4% | — |
| Q1 26 | 5.6% | — | ||
| Q4 25 | 9.5% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 4.7% | 71.2% | ||
| Q4 24 | -4.0% | -46.4% | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 7.9% | — |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $0.04 | $1.90 | ||
| Q4 24 | $-0.06 | $-0.15 | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $350.1M |
| Total Assets | $3.0B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.3M | — | ||
| Q4 25 | $68.1M | — | ||
| Q3 25 | $145.3M | — | ||
| Q2 25 | $52.4M | — | ||
| Q1 25 | $100.6M | $274.8M | ||
| Q4 24 | $81.4M | $128.0M | ||
| Q3 24 | $75.3M | — | ||
| Q2 24 | $125.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.2B | — |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | $350.1M | ||
| Q4 24 | $1.6B | $229.0M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.1B | $406.9M | ||
| Q4 24 | $3.2B | $271.6M | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $67.9M | — | ||
| Q3 25 | $74.6M | — | ||
| Q2 25 | $73.6M | — | ||
| Q1 25 | $27.6M | $131.8M | ||
| Q4 24 | $75.8M | $-23.2M | ||
| Q3 24 | $61.7M | — | ||
| Q2 24 | $55.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | — | ||
| Q3 25 | $54.9M | — | ||
| Q2 25 | $57.9M | — | ||
| Q1 25 | $2.0M | $131.7M | ||
| Q4 24 | $52.6M | $-23.2M | ||
| Q3 24 | $39.0M | — | ||
| Q2 24 | $38.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | — | ||
| Q3 25 | 19.2% | — | ||
| Q2 25 | 18.9% | — | ||
| Q1 25 | 0.8% | 83.0% | ||
| Q4 24 | 18.9% | -102.7% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 12.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 10.0% | 0.1% | ||
| Q4 24 | 8.3% | 0.2% | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 5.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | — | ||
| Q3 25 | 3.31× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 2.33× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 2.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
STOK
Segment breakdown not available.
